We performed a similar experiment in PA-TU-8902 pancreatic cancer cells, and found that while pravastatin did not affect translocation of the K-Ras protein to the cell membrane, cerivastatin significantly prevented GFP-K-Ras from membrane localization. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.